The earnings call indicates a solid start to the fiscal year with strong admissions and revenue growth, operational improvements, and strategic acquisitions. However, challenges such as payer claim denials and delays in CMS approval present headwinds.

Company Guidance

During Ardent Health Partners' first-quarter 2025 earnings call, the company reaffirmed its full-year financial guidance, highlighting several key metrics and strategic initiatives. Admissions grew by 7.6%, with inpatient surgeries up 3.4% and adjusted admissions increasing by 2.7%, aligning with their full-year outlook of 2% to 3%. Revenue rose by 4% to $1.5 billion, driven by strong market demand, despite a 70 basis point headwind from transferring certain services. Adjusted EBITDA increased by 2.5% to $98 million, supported by a 60 basis point reduction in supply costs as a percentage of revenue. The company reported solid cash liquidity of $495 million and a lease-adjusted net leverage ratio of 3 times. Strategic efforts focused on expanding outpatient and acute care footprints, with a $500 million cash reserve aiding this expansion. Ardent emphasized disciplined operational improvements, aiming for 100 to 200 basis points of margin expansion over the next several years.

Strong Admissions and Revenue Growth

Admissions grew 7.6% driven by strong underlying growth and heightened flu season. First quarter revenue increased 4% to $1.5 billion compared to the prior year.

Operational Improvements and Cost Efficiency

Supply cost as a percent of revenue declined 60 basis points year-over-year. Contract labor costs declined 60 basis points year-over-year to 3.8% of total salaries and benefits.

NextCare Acquisition Integration

Integration of 18 NextCare urgent care clinics expected to generate additional downstream volumes in Tulsa and Albuquerque markets.

Positive Market Position and Outlook

The company reaffirms full year 2025 financial guidance. S&P upgraded credit rating to B+ from B, reflecting improved net leverage and cash flow profile.

Ardent Health Partners, Inc. (ARDT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ARDT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	0.41 / -	0.19	―	―	―
Aug 05, 2025	2025 (Q2)	0.23 / 0.52	0.34	52.94% (+0.18)
May 06, 2025	2025 (Q1)	0.20 / 0.29	0.21	38.10% (+0.08)
Feb 26, 2025	2024 (Q4)	0.48 / 0.81	-0.029	2893.10% (+0.84)
Nov 06, 2024	2024 (Q3)	0.31 / 0.19	0.146	30.14% (+0.04)
Aug 14, 2024	2024 (Q2)	0.31 / 0.34	0.232	46.55% (+0.11)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ARDT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$10.65	$11.30	+6.10%
May 06, 2025	$13.01	$14.21	+9.22%
Feb 26, 2025	$14.01	$15.16	+8.21%
Nov 06, 2024	$16.27	$17.54	+7.81%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ardent Health Partners, Inc. (ARDT) report earnings?

Ardent Health Partners, Inc. (ARDT) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Ardent Health Partners, Inc. (ARDT) earnings time?

Ardent Health Partners, Inc. (ARDT) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ARDT EPS forecast?

ARDT EPS forecast for the fiscal quarter 2025 (Q3) is 0.42.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing